Johnson & Johnson

Johnson & Johnson Receives FDA Market Authorization in the U.S. for its OTTAVA Robotic Surgical System

Johnson & Johnson - Johnson & Johnson announced that the FDA has granted De Novo authorization for the OTTAVA Robotic Surgical System, the world’s first table-integrated soft tissue robotic system. The system received marketing authorization for multiple procedures in general surgery, including Roux-en-Y gastric bypass, gastrectomy, cholecystectomy, splenectomy, gastric sleeve, small bowel resection, appendectomy, lysis of adhesions, fundoplication, and hiatal hernia repair.